NSG 533 Opioid Quiz With Correct Answers., Exams of Nursing

NSG 533 Opioid Quiz With Correct Answers.

Typology: Exams

2025/2026

Available from 03/21/2026

STUDYCHAMPION
STUDYCHAMPION 🇺🇸

2.4K documents

1 / 5

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
NSG //533 //Opioid //Quiz //With //Correct //Answers //
Endogenous //opioid //peptides
Small //molecules //that //are //naturally //produced //in //the //CNS //and //in //various //glands
//throughout //the //body, //such //as //the //pituitary //and //adrenal //glands. //Consists //of //endorphins,
//enkephalins, //dynorphins, //and //nociceptins.
Mechanism //of //action //for //opioids
Stimulating //opioid //u-receptors //in //the //CNS. //Pure //agonists //(morphine) //bind //to //u-receptors
//to //produce //analgesia //that //increases //with //dose //without //a //ceiling //effect. //Partial //agonists
//at //the //u-receptor //(Buprenorphine, //tramadol) //cause //less //conformational //change //and
//receptor //activation //than //full //agonists.
Indications //for //initiating //opioid //therapy
Used //when //benefits //outweigh //risks //associated //with //opioids //such //as //abuse. //Used //for
//acute //pain //(including //post-surgical) //from //under //a //month, //and //chronic //pain.
Tolerance
the //diminishing //effect //with //regular //use //of //the //same //dose //of //a //drug, //requiring //the //user
//to //take //larger //and //larger //doses //before //experiencing //the //drug's //effect
Dependence
the //condition //that //results //when //the //brain //develops //a //chemical //need //for //a //drug //and
//cannot //function //normally //without //it
pf3
pf4
pf5

Partial preview of the text

Download NSG 533 Opioid Quiz With Correct Answers. and more Exams Nursing in PDF only on Docsity!

NSG // 533 //Opioid //Quiz //With //Correct //Answers //

Endogenous //opioid //peptides Small //molecules //that //are //naturally //produced //in //the //CNS //and //in //various //glands //throughout //the //body, //such //as //the //pituitary //and //adrenal //glands. //Consists //of //endorphins, //enkephalins, //dynorphins, //and //nociceptins. Mechanism //of //action //for //opioids Stimulating //opioid //u-receptors //in //the //CNS. //Pure //agonists //(morphine) //bind //to //u-receptors //to //produce //analgesia //that //increases //with //dose //without //a //ceiling //effect. //Partial //agonists //at //the //u-receptor //(Buprenorphine, //tramadol) //cause //less //conformational //change //and //receptor //activation //than //full //agonists. Indications //for //initiating //opioid //therapy Used //when //benefits //outweigh //risks //associated //with //opioids //such //as //abuse. //Used //for //acute //pain //(including //post-surgical) //from //under //a //month, //and //chronic //pain. Tolerance the //diminishing //effect //with //regular //use //of //the //same //dose //of //a //drug, //requiring //the //user //to //take //larger //and //larger //doses //before //experiencing //the //drug's //effect Dependence the //condition //that //results //when //the //brain //develops //a //chemical //need //for //a //drug //and //cannot //function //normally //without //it

Addiction A //physiological //or //psychological //dependence //on //a //drug Neuralgia nerve //pain Analgesia Pain //relief; //inability //to //feel //pain Allodynia Pain //due //to //a //stimulus //that //does //not //normally //provoke //pain When //to //initiate //long-acting //opioids If //the //short-acting //opioids //are //not //working //as //well //in //chronic //pain //or //end-of-life //pain, //or //the //patient //feels //as //though //their //regular //dose //is //not //as //effective. Abuse //deterrent //opioids Designed //to //prevent //these //altered //routes //of //administration, //while //retaining //efficacy //with //oral //administration //for //legitimate //pain //relief. //Hydrocodone, //oxycontin

Can //influence //the //shape //and //number //of //drug //receptors, //affecting //the //intensity //of //response. //Can //require //higher //doses //of //opioids //to //work. Adverse //effects //of //opioids Effects //include //central //nervous //system //depression, //respiratory //depression, //hypotension, //flushing, //palpitations, //constipation, //nausea //and //vomiting, //urinary //retention, //itching, //rash, //and //biliary //tract //spasm. Options //available //for //medication-assisted //treatment //(MAT) Buprenorphine //(suboxone), //methadone, //and //naltrexone Prescribing //restrictions //for //MAT Must //apply //for //federal //approval //to //prescribe //suboxone //prescription. //Must //take //a //course // 8 - 24 //hours. //Apply //for //a //special //ID //number //from //the //DEA, //subject //pt //records //to //DEA //scrutinization. Who //is //at //risk? Young //adults, //mental //health //disorders Concerns //regarding //naloxone //administration Risks //are //related //to //opioid-dependent //patients. //This //can //induce //withdrawal //symptoms, //may //wear //off //prematurely //when //used //for //respiratory //depression, //high-dose //naloxone

//or //rapidly //administered //naloxone //may //cause //catecholamine //release //therefore //causing //pulmonary //edema, //and //cardiac //arrythmias Who //should //naloxone //be //prescribed //to? Taking //high-dose //opioids //for //long-term //management //of //chronic //pain, //receive //rotating //opioid //medication //regimens, //have //been //discharged //following //opioid //OD, //take //certain //extended-release //or //long-acting //opioids, //those //who //have //a //period //of //abstinence //from //incarceration //etc Education //on //use //of //naloxone Insert //the //nozzle //into //one //nostril //until //your //fingers //on //either //side //side //of //the //nozzle //are //against //the //bottom //of //the //nose